Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|December 11, 2007
CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphomaRaymond I Cruz, Francisco J Hernandez-Ilizaliturri, Scott Olejniczak, et al.
BMJ Open|June 18, 2016
Implementing referral to an electronic alcohol brief advice website in primary healthcare: results from the ODHIN implementation trialPreben Bendtsen, Ulrika Müssener, Nadine Karlsson, et al.
Atherosclerosis|July 25, 2013
Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral bloodZohara Sternberg, Husam Ghanim, Kristen M Gillotti, et al.
BMJ Open|January 2, 2015
A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocolHugo López-Pelayo, Paul Wallace, Lidia Segura, et al.
American Journal of Physiology. Renal Physiology|November 5, 2019
Dietary phosphate restriction attenuates polycystic kidney disease in miceFaith Omede, Shiqin Zhang, Cassandra Johnson, et al.
Transplantation and Cellular Therapy|November 27, 2022
Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34<sup>+</sup> and CD34<sup>+</sup>CD38<sup>-</sup>CD45RA<sup>-</sup>CD90<sup>+</sup> CellsAmro Elshoury, Orla Maguire, Alexis Conway, et al.
Current HIV Research|March 14, 2008
Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and lightZale P Bernstein, Thomas Dougherty, Sandra Gollnick, et al.
Rhode Island Medical Journal (2013)|May 27, 2026
Implementing Behavioral Health Services at a Community-Based LGBTQ+ ClinicPhilip A Chan, Peter Salhaney, Jen Etue, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 14, 2017
A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin LymphomaPallawi Torka, Priyank Patel, Wei Tan, et al.
Blood|July 30, 2005
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)Asher Chanan-Khan, Kena C Miller, Kenichi Takeshita, et al.
Pageof 9